Dermatological manifestation in a patient with COVID-19
Main Author: | |
---|---|
Publication Date: | 2020 |
Other Authors: | , , |
Format: | Article |
Language: | por |
Source: | Revista Científica da Faculdade de Medicina de Campos |
Download full: | https://www.fmc.br/ojs/index.php/RCFMC/article/view/409 |
Summary: | Introduction: In December 2019, the first group of people infected with the new coronavirus, SARS-CoV-2, appeared in China, and in 2020 the disease reached global proportions and was classified as a pandemic. Dermatological manifestations of COVID-19 infection occur with a frequency of 20% in hospitalized patients with no history of drug exposure in the previous two weeks. Aims: To report urticarial manifestations in a patient with COVID-19, suggesting that such lesions may be an expression of the clinical dermatological polymorphism presented during infection with the new coronavirus. Case report: A 27-year-old patient presents initial clinical picture with runny nose, cough and fatigue. He evolved with anosmia, dysgeusia and worsening cough. On the tenth day of the disease, the patient presented ponphous lesions of follicular and interfolicular distribution that coalesce and formed erythematous, itchy plaques, lasting approximately 30 minutes and spontaneous resolution, located on the trunk and upper and lower limbs. The diagnosis was acute urticaria related to SARS-CoV2 infection. Conclusion: Covid-19 presents a variable clinical picture, with a wide spectrum of symptoms ranging from asymptomatic pictures to severe systemic disease. The injuries presented by the patient have already been reported in the literature as signs related to infection by SARS-CoV-2. The identification of dermatological manifestations is of utmost importance, being one more relevant data for suspicion of infection, allowing symptomatic management and early isolation to interrupt the disease transmission chain. |
id |
FMC-0_934338d6b07cb70b09aba5d60a9fea93 |
---|---|
oai_identifier_str |
oai:ojs.www.fmc.br:article/409 |
network_acronym_str |
FMC-0 |
network_name_str |
Revista Científica da Faculdade de Medicina de Campos |
repository_id_str |
|
spelling |
Dermatological manifestation in a patient with COVID-19MANIFESTAÇÃO DERMATOLÓGICA EM PACIENTE COM COVID-19COVID-19DermatologiaInfecções por CoronavirusUrticáriaCovid-19DermatologyCoronavirus InfectionsUrticariaIntroduction: In December 2019, the first group of people infected with the new coronavirus, SARS-CoV-2, appeared in China, and in 2020 the disease reached global proportions and was classified as a pandemic. Dermatological manifestations of COVID-19 infection occur with a frequency of 20% in hospitalized patients with no history of drug exposure in the previous two weeks. Aims: To report urticarial manifestations in a patient with COVID-19, suggesting that such lesions may be an expression of the clinical dermatological polymorphism presented during infection with the new coronavirus. Case report: A 27-year-old patient presents initial clinical picture with runny nose, cough and fatigue. He evolved with anosmia, dysgeusia and worsening cough. On the tenth day of the disease, the patient presented ponphous lesions of follicular and interfolicular distribution that coalesce and formed erythematous, itchy plaques, lasting approximately 30 minutes and spontaneous resolution, located on the trunk and upper and lower limbs. The diagnosis was acute urticaria related to SARS-CoV2 infection. Conclusion: Covid-19 presents a variable clinical picture, with a wide spectrum of symptoms ranging from asymptomatic pictures to severe systemic disease. The injuries presented by the patient have already been reported in the literature as signs related to infection by SARS-CoV-2. The identification of dermatological manifestations is of utmost importance, being one more relevant data for suspicion of infection, allowing symptomatic management and early isolation to interrupt the disease transmission chain.Introdução: Em dezembro de 2019, surgiu na China o primeiro grupo de pessoas infectadas com o novo coronavírus, SARS-CoV-2, e em 2020 a doença atingiu proporções globais sendo classificada como uma pandemia. As manifestações dermatológicas da infecção por COVID-19 acontecem com uma frequência de 20% em doentes hospitalizados sem história de exposição a medicamentos nas duas semanas anteriores. Objetivo: Relatar manifestações urticariformes em paciente com COVID-19, sugerindo que tais lesões podem ser expressão do polimorfismo clínico dermatológico, apresentado durante a infecção pelo novo coronavírus. Relato de caso: Paciente de 27 anos apresenta quadro clínico inicial com coriza, tosse e fadiga. Evoluiu com anosmia, disgeusia e piora da tosse. No décimo dia de doença, o paciente apresentou lesões ponfosas de distribuição folicular e interfolicular que coalesciam e formavam placas eritematosas, pruriginosas, com duração de aproximadamente 30 minutos e resolução espontânea, localizadas no tronco e membros superiores e inferiores. O diagnóstico foi de urticária aguda relacionada à infecção pelo SARS-CoV2. Conclusão: A Covid-19 apresenta quadro clínico variável, com um amplo espectro de sintomatologia que abrange desde quadros assintomáticos até doença sistêmica grave. As lesões apresentadas pelo paciente já foram relatadas na literatura como sinais relacionados à infecção pelo SARS-CoV-2. É de suma importância a identificação de manifestações dermatológicas, sendo mais um dado relevante para suspeição de infecção, permitindo manejo sintomático e isolamento precoce para interromper a cadeia de transmissão da doença.Faculdade de Medicina de Campos (FMC)2020-10-14info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.fmc.br/ojs/index.php/RCFMC/article/view/40910.29184/1980-7813.rcfmc.409.vol.15.n2.2020Scientific Journal of the Medical School of Campos; Vol. 15 No. 2 (2020): Edição COVID-19; 47-50Revista Científica da Faculdade de Medicina de Campos; v. 15 n. 2 (2020): Edição COVID-19; 47-501980-7813reponame:Revista Científica da Faculdade de Medicina de Camposinstname:Faculdade de Medicina de Campos (FMC)instacron:FMCporhttps://www.fmc.br/ojs/index.php/RCFMC/article/view/409/216Copyright (c) 2020 Revista Científica da Faculdade de Medicina de Camposhttps://creativecommons.org/licenses/by-sa/4.0info:eu-repo/semantics/openAccessSouza, David AlmeidaAlves, Ana LuísaBaka, Jessica Lana Conceição e SilvaAzulay-Abulafia, Luna2021-01-11T12:21:01Zoai:ojs.www.fmc.br:article/409Revistahttps://www.fmc.br/ojs/index.php/RCFMC/PRIhttps://www.fmc.br/ojs/index.php/RCFMC/oai||revista@fmc.br1980-78131980-7813opendoar:2021-01-11T12:21:01Revista Científica da Faculdade de Medicina de Campos - Faculdade de Medicina de Campos (FMC)false |
dc.title.none.fl_str_mv |
Dermatological manifestation in a patient with COVID-19 MANIFESTAÇÃO DERMATOLÓGICA EM PACIENTE COM COVID-19 |
title |
Dermatological manifestation in a patient with COVID-19 |
spellingShingle |
Dermatological manifestation in a patient with COVID-19 Souza, David Almeida COVID-19 Dermatologia Infecções por Coronavirus Urticária Covid-19 Dermatology Coronavirus Infections Urticaria |
title_short |
Dermatological manifestation in a patient with COVID-19 |
title_full |
Dermatological manifestation in a patient with COVID-19 |
title_fullStr |
Dermatological manifestation in a patient with COVID-19 |
title_full_unstemmed |
Dermatological manifestation in a patient with COVID-19 |
title_sort |
Dermatological manifestation in a patient with COVID-19 |
author |
Souza, David Almeida |
author_facet |
Souza, David Almeida Alves, Ana Luísa Baka, Jessica Lana Conceição e Silva Azulay-Abulafia, Luna |
author_role |
author |
author2 |
Alves, Ana Luísa Baka, Jessica Lana Conceição e Silva Azulay-Abulafia, Luna |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Souza, David Almeida Alves, Ana Luísa Baka, Jessica Lana Conceição e Silva Azulay-Abulafia, Luna |
dc.subject.por.fl_str_mv |
COVID-19 Dermatologia Infecções por Coronavirus Urticária Covid-19 Dermatology Coronavirus Infections Urticaria |
topic |
COVID-19 Dermatologia Infecções por Coronavirus Urticária Covid-19 Dermatology Coronavirus Infections Urticaria |
description |
Introduction: In December 2019, the first group of people infected with the new coronavirus, SARS-CoV-2, appeared in China, and in 2020 the disease reached global proportions and was classified as a pandemic. Dermatological manifestations of COVID-19 infection occur with a frequency of 20% in hospitalized patients with no history of drug exposure in the previous two weeks. Aims: To report urticarial manifestations in a patient with COVID-19, suggesting that such lesions may be an expression of the clinical dermatological polymorphism presented during infection with the new coronavirus. Case report: A 27-year-old patient presents initial clinical picture with runny nose, cough and fatigue. He evolved with anosmia, dysgeusia and worsening cough. On the tenth day of the disease, the patient presented ponphous lesions of follicular and interfolicular distribution that coalesce and formed erythematous, itchy plaques, lasting approximately 30 minutes and spontaneous resolution, located on the trunk and upper and lower limbs. The diagnosis was acute urticaria related to SARS-CoV2 infection. Conclusion: Covid-19 presents a variable clinical picture, with a wide spectrum of symptoms ranging from asymptomatic pictures to severe systemic disease. The injuries presented by the patient have already been reported in the literature as signs related to infection by SARS-CoV-2. The identification of dermatological manifestations is of utmost importance, being one more relevant data for suspicion of infection, allowing symptomatic management and early isolation to interrupt the disease transmission chain. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-10-14 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.fmc.br/ojs/index.php/RCFMC/article/view/409 10.29184/1980-7813.rcfmc.409.vol.15.n2.2020 |
url |
https://www.fmc.br/ojs/index.php/RCFMC/article/view/409 |
identifier_str_mv |
10.29184/1980-7813.rcfmc.409.vol.15.n2.2020 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://www.fmc.br/ojs/index.php/RCFMC/article/view/409/216 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2020 Revista Científica da Faculdade de Medicina de Campos https://creativecommons.org/licenses/by-sa/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2020 Revista Científica da Faculdade de Medicina de Campos https://creativecommons.org/licenses/by-sa/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Faculdade de Medicina de Campos (FMC) |
publisher.none.fl_str_mv |
Faculdade de Medicina de Campos (FMC) |
dc.source.none.fl_str_mv |
Scientific Journal of the Medical School of Campos; Vol. 15 No. 2 (2020): Edição COVID-19; 47-50 Revista Científica da Faculdade de Medicina de Campos; v. 15 n. 2 (2020): Edição COVID-19; 47-50 1980-7813 reponame:Revista Científica da Faculdade de Medicina de Campos instname:Faculdade de Medicina de Campos (FMC) instacron:FMC |
instname_str |
Faculdade de Medicina de Campos (FMC) |
instacron_str |
FMC |
institution |
FMC |
reponame_str |
Revista Científica da Faculdade de Medicina de Campos |
collection |
Revista Científica da Faculdade de Medicina de Campos |
repository.name.fl_str_mv |
Revista Científica da Faculdade de Medicina de Campos - Faculdade de Medicina de Campos (FMC) |
repository.mail.fl_str_mv |
||revista@fmc.br |
_version_ |
1798042302045749248 |